Nurix’s mission is to develop innovative therapies that improve patient outcomes by harnessing the power

Nurix’s mission is to develop innovative therapies that improve patient outcomes by harnessing the power of the body’s natural protein degradation machinery. The company’s vision is to lead the field of targeted protein degradation, delivering life−changing treatments for patients worldwide. Nurix’s proprietary DELigase platform is designed to identify and develop small molecules that can selectively recruit E3 ligases to target proteins for degradation. This platform enables the discovery of therapies that can precisely degrade disease causing proteins.By modulating the activity of E3 ligases, Nurix’s therapies can selectively remove specific proteins within the cell, offering a novel approach to treating diseases that are currently difficult to address with traditional small molecules or biologics.